Switch to:
More From Other Websites
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Aug 28 2014
1:18 am Repros Therapeutics achieves superiority in top line analysis for both co-primary endpoints... Aug 28 2014
Androxal(R) Achieves Superiority in Top Line Analysis for Both Co-Primary Endpoints and Various... Aug 27 2014
Repros Therapeutics (RPRX) Shows Strength: Stock Rises 5% Aug 22 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Aug 20 2014
REPROS THERAPEUTICS INC. Financials Aug 19 2014
Repros Therapeutics Q2 Loss a Penny Wider than Expected Aug 12 2014
Repros Therapeutics Inc.(R) Reports Second Quarter 2014 Financial Results Aug 11 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition Aug 11 2014
Repros Therapeutics Inc.(R) Reports Second Quarter 2014 Financial Results Aug 11 2014
Repros Gets Additional FDA Guidance for Androxal Jul 17 2014
FDA Confirms Sperm and Testosterone Endpoints as Key Parameters for Assessment of Androxal(R) Versus... Jul 16 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Jul 16 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission... Jun 20 2014
Repros Therapeutics reaches enrollment goal in second Androxal study May 13 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure May 13 2014
Repros' Q1 Loss In Line with Expectations May 13 2014
Repros Therapeutics reports Q1 EPS (37c), consensus (35c) May 12 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition May 12 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure May 08 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK